Cytochrome P-450 activities in human and rat brain microsomes

Brain Research

Volumn 855, Issue 2, 2000, Pages 235-243

  Voirol, Pierre ^a   Jonzier Perey, Michèle ^a   Porchet, François ^b   Reymond, Marianne J ^b   Janzer, Robert C ^b   Bouras, Constantin ^c   Strobel, Henry W ^d   Kosel, Markus ^a   Eap, Chin B ^a   Baumann, Pierre ^a  

^a DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c HUG   (Switzerland)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Cytochrome P 450; Human brain; Metabolism; Microsome; Psychotropic drug; Rat brain

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; CYTOCHROME P450; DEXTROMETHORPHAN; DRUG METABOLITE; FLUOXETINE; FURAFYLLINE; KETOCONAZOLE; MEPHENYTOIN; MIDAZOLAM; PSYCHOTROPIC AGENT; QUINIDINE; SERTRALINE; SULFAPHENAZOLE;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; BRAIN MICROSOME; CONTROLLED STUDY; DEMETHYLATION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AGED; AGED, 80 AND OVER; ANIMALS; BRAIN; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; ISOENZYMES; KINETICS; MALE; MICROSOMES; MIDDLE AGED; RATS; RATS, WISTAR;

EID: 0034645927     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02354-9     Document Type: Article

References (48)

1. Backes W.L., Batie C.J., Cawley G.F. Interactions among P450 enzymes when combined in reconstituted systems: formation of a 2B4-1A2 complex with a high affinity for NADPH-cytochrome P450 reductase. Biochemistry. 37:1998;12852-12859.
2. Baumann P., Gaillard J.-M., Jonzier-Perey M., Gerber C., Bouras C. Evaluation of the levels of free and total amitriptyline and metabolites in the plasma and brain of the rat after long-term administration of doses used in receptor studies. Psychopharmacology. 84:1984;489-495.
3. Baumann P., Jonzier-Perey M. GC and GC-MS procedures for simultaneous phenotyping with dextromethorphan and mephenytoin. Clin. Chim. Acta. 171:1988;211-222.
4. Baumann P., Jonzier-Perey M., Koeb L., Le P.K., Tinguely D., Schöpf J. Amitriptyline pharmacokinetics and clinical response: I. Free and total plasma amitriptyline and nortriptyline. Int. Clin. Psychopharmacol. 1:1986;89-101.
5. Baumann P., Koeb L., Tinguely D., Rivier L. A method for the analysis of free, total plasma and saliva amitriptyline and nortriptyline by dialysis and gc/ms, Eur. J. Mass. Spectr. Biochem. Med. Environm. Res. 2:1982;19-26.
6. P., Baumann, M. Kosel, P. Voirol, Pharmakogenetische charakterisierung in der psychiatrie, in: AnonymousLaboruntersuchungen in der Psychiatrischen Routine, Thieme, Stuttgart, in press.
7. Bertilsson L., Dahl M.-L. Polymorphic drug oxidationrelevance to the treatment of psychiatric disorders. CNS Drugs. 5:1996;200-223.
8. Bhagwat S.V., Boyd M.R., Ravindranath V. Brain mitochondrial cytochromes P450: xenobiotic metabolism, presence of multiple forms and their selective inducibility. Arch. Biochem. Biophys. 320:1995;73-83.
9. Bhamre S., Anandatheerthavarada H.K., Shankar S.K., Boyd M.R., Ravindranath V. Purification of multiple forms of cytochrome P450 from a human brain and reconstitution of catalytic activities. Arch. Biochem. Biophys. 301:1993;251-255.
10. Breyer-Pfaff U., Pfandl B., Nill K., Nusser E., Monney C., Jonzier-Perey M., Baettig D., Baumann P. Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isozymes. Clin. Pharmacol. Ther. 52:1992;350-358.
11. Br¢sen K. Drug-metabolizing enzymes and therapeutic drug monitoring in psychiatry. Ther. Drug Monit. 18:1996;393-396.
12. Chat M., Bayol-Denizot C., Suleman G., Roux F., Minn A. Drug metabolizing enzyme activities and superoxide formation in primary and immortalized rat brain endothelial cells. Life Sci. 62:1998;151-163.
13. Christensen P.M., Gotzsche P.C., Br¢sen K. The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of Parkinson's disease: a meta-analysis. Pharmacogenetics. 8:1998;473-479.
14. Eagling V.A., Tjia J.F., Back D.J. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. Br. J. Clin. Pharmacol. 45:1998;107-114.
15. Eap C.B., Bouchoux G., Amey M., Cochard N., Savary L., Baumann P. Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry. J. Chromatogr. Sci. 36:1998;365-371.
16. Eap C.B., Gaillard N., Powell K., Baumann P. Simultaneous determination of plasma levels of fluvoxamine and of the enantiomers of fluoxetine and norfluoxetine by gas chromatography-mass spectrometry. J. Chromatogr. B: Biomed. Appl. 682:1996;265-272.
17. Eyles D.W., McGrath J.J., Pond S.M. Formation of pyridinium species of haloperidol in human liver and brain. Psychopharmacology. 125:1996;214-219.
18. Fonne-Pfister R., Bargetzi M.J., Meyer U.A. MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450buf I, P450db1) catalyzing debrisoquine 4-hydroxylation. Biochem. Biophys. Res. Commun. 148:1987;1144-1150.
19. Ghersi-Egea J.F., Perrin R., Leininger-Muller B., Grassiot M.-C., Jeandel C., Floquet J., Cuny G., Siest G., Minn A. Subcellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain. Biochem. Pharmacol. 45:1993;647-658.
20. Gilham D.E., Cairns W., Paine M.J.I., Modi S., Poulsom R., Roberts G.C.K., Wolf C.R. Metabolism of MPTP by cytochrome P4502D6 and the demonstration of 2D6 mRNA in human foetal and adult brain by in situ hybridization. Xenobiotica. 27:1997;111-125.
21. Gum J.R., Strobel H.W. Purified NADPH cytochrome P-450 reductase. Interaction with hepatic microsomes and phospholipid vesicles. J. Biol. Chem. 254:1979;4177-4185.
22. Hedlund E., Gustafsson J.-A., Warner M. Cytochrome P450 in the brain2B or not 2B. Trends Pharmacol. Sci. 19:1998;82-85.
23. Hiroi T., Imaoka S., Chow T., Funae Y. Tissue distributions of CYP2D1, 2D2, 2D3, and 2D4 mRNA in rats detected by RT-PCR. Biochim. Biophys. Acta. 1380:1998;305-312.
24. Igarashi K. The possible role of an active metabolite derived from the neuroleptic agent haloperidol in drug-induced Parkinsonism. J. Toxicol., Toxin Rev. 17:1998;27-38.
25. Jacob Ill P., Ulgen M., Gorrod J.W. Metabolism of (-)-(S)-nicotine by guinea pig and rat brain: identification of cotinine. Eur. J. Drug Metab. Pharmacokinet. 22:1997;391-394.
26. Jolivalt C., Minn A., Vincent-Viry M., Galteau M.M., Siest G. Dextromethorphan O-demethylase activity in rat brain microsomes. Neurosci. Lett. 187:1995;65-68.
27. Kawashima H., Sequeira D.J., Nelson D.R., Strobel H.W. Genomic cloning and protein expression of a novel rat brain cytochrome P-450 CYP2D18 catalyzing imipramine N-demethylation. J. Biol. Chem. 271:1996;28176-28180.
28. A. Küpfer, R. James, K. Carr, R. Branch, Analysis of hydroxylated and demthylated metabolites of mephenytoin in man and laboratory animals using gas-liquid chromatography and high-performance liquid chromatography, J. Chromatogr. Biomed. Appl. (1982) 93-100.
29. Martens J., Banditt P. Simultaneous determination of midazolam and its metabolites 1-hydroxymidazolam and 4-hydroxymidazolam in human serum using gas chromatography-mass spectrometry. J. Chromatogr. B. 692:1997;95-100.
30. Mäenpää J., Hall S.D., Ring B.J., Strom S.C., Wrighton S.A. Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone. Pharmacogenetics. 8:1998;137-155.
31. McCann S.J., Pond S.M., James K.M., Le Couteur D.G. The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's-disease: a case-control study and meta-analysis. J. Neurol. Sci. 153:1997;50-53.
32. McFadyen M.C.E., Melvin W.T., Murray G.I. Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain. Biochem. Pharmacol. 55:1998;825-830.
33. Meyer U.A., Amrein R., Balant L.P., Bertilsson L., Eichelbaum M., Guentert T.W., Henauer S., Jackson P., Laux G., Mikkelsen H., Peck C., Pollock B.G., Priest R., Sjöqvist F., Delini-Stula A. Antidepressants and drug-metabolizing enzymesexpert group report. Acta Psychiatr. Scand. 93:1996;71-79.
34. Morse D.C., Stein A.P., Thomas P.E., Lowndes H.E. Distribution and induction of cytochrome P450 1A1 and 1A2 in rat brain. Toxicol. Appl. Pharmacol. 152:1998;232-239.
35. Olesen O.V., Linnet K. Metabolism of the tricyclic antidepressant amitriptyline by cDNA-expressed human cytochrome P450 enzymes. Pharmacology. 55:1997;235-243.
36. Ray-Chaudhuri K., Smith C.A.D., Gough A.C., Novak N., Chamoun V., Wolf C.R., Leigh P.N. Debrisoquine hydroxylase gene polymorphism in Parkinson's disease and amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 58:1995;109.
37. Rieder C.R.M., Ramsden D.B., Williams A.C. Cytochrome P450 1B1 mRNA in the human central nervous system. J. Clin. Pathol. 51:1998;138-142.
38. Riedl A.G., Watts P.M., Jenner P., Marsden C.D. P450 enzymes and Parkinson's disease: the story so far. Mov. Disord. 13:1998;212-220.
39. Saitoh T., Xia Y., Chen X., Masliah E., Galasko D., Shults C., Thal L.J., Hansen L.A., Katzman R. The CYP2D6B mutant allele is overrepresented in the lewy body variant of Alzheimer's disease. Ann. Neurol. 37:1995;110-112.
40. Schmider J., Greenblatt D.J., Harmatz J.S., Shader R.I. Enzyme kinetic modelling as a tool to analyse the behaviour of cytochrome P450 catalysed reactions: application to amitriptyline N-demethylation. Br. J. Clin. Pharmacol. 41:1996;593-604.
41. Sequeira D.J., Strobel H.W. In vitro metabolism of imipramine by brain microsomes: effects of inhibitors and exogenous cytochrome P450 reductase. Brain Res. 738:1996;24-31.
42. Shen W.W. The metabolism of psychoactive drugs: a review of enzymatic biotransformation and inhibition. Biol. Psychiatry. 41:1997;814-826.
43. Stanton J.M. Weight gain associated with neuroleptic medication: a review. Schizophr. Bull. 21:1995;463-472.
44. Thompson C.M., Kawashima H., Strobel H.W. Isolation of partially purified P450 2D18 and characterization of activity toward the tricyclic antidepressants imipramine and desipramine. Arch. Biochem. Biophys. 359:1998;115-121.
45. Tirumalai P.S., Bhamre S., Upadhya S.C., Boyd M.R., Ravindranath V. Expression of multiple forms of cytochrome P450 and associated mono-oxygenase activities in rat brain regions. Biomed. Chromatogr. 56:1998;371-375.
46. Venkatakrishnan K., Greenblatt D.J., Von Moltke L.L., Schmider J., Harmatz J.S., Shader R.I. Five distinct human cytochromes mediate amitriptyline N- demethylation in vitro: dominance of CYP 2C19 and 3A4. J. Clin. Pharmacol. 38:1998;112-121.
47. Voirol P., Aubert A.-C., Jonzier-Perey M., Baumann P. An automated procedure for the determination of protein concentration in subcellular fractions. Clin. Chim. Acta. 273:1998;89-93.
48. Wyss A., Gustafsson J.-A., Warner M. Cytochromes P450 of the 2D subfamily in rat brain. Mol. Pharmacol. 47:1995;1148-1155.